Trypanosomatid protein kinases as potential drug targets.

Wiese, M. and Morris, A. and Grant, Karen M. (2009) Trypanosomatid protein kinases as potential drug targets. In: Antiparasitic and antibacterial drug discovery : from molecular targets to drug candidates. Drug Discovery in Infectious Diseases. . Wiley-VCH, Weinheim, pp. 227-247. ISBN 978-3-527-32327-2

Full text not available from this repository.


The trypanosomatid protozoa include the medically important parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania. They are responsible for a wide range of diseases which blight the developing nations of the world. Current chemotherapy to treat these diseases is far from ideal and many different approaches are being taken to identify new drug targets. One family of potential drug targets are the protozoan protein kinases. Protein kinases are ubiquitous in eukaryotes and act in many different intracellular signalling pathways affecting for example: differentiation, proliferation, motility, and apoptosis. Within parasitic protozoa, several protein kinases play essential roles and disruption of their activity is seriously deleterious to the parasite. Moreover, despite homology to their mammalian counterparts, protozoan protein kinases are significantly different in ways which open up the possibility of developing parasite-selective inhibitors. In this article, we will outline the current knowledge of important parasite protein kinases and discuss their suitability as novel drug targets.

Item Type: Contribution in Book/Report/Proceedings
Uncontrolled Keywords: /dk/atira/pure/researchoutput/libraryofcongress/r1
Departments: Faculty of Science and Technology > Lancaster Environment Centre
Faculty of Health and Medicine > Medicine
ID Code: 26895
Deposited By: Dr Karen Grant
Deposited On: 12 Aug 2009 08:56
Refereed?: No
Published?: Published
Last Modified: 30 Sep 2019 10:24

Actions (login required)

View Item View Item